TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25312554

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of insulin (group 1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Subcutaneous injections of insulin glargine (group 2)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Insulin dosage during 6-month follow-up
Number of subjects: 30
Study: 20522796

Group type: EXPERIMENTAL
Intervention: Intermittent subglottic secretion drainage (SSD)
Number of subjects: 333

Group type: COMPARATOR
Intervention: Control (no SSD)
Number of subjects: 333
Study: 16135587

Group type: EXPERIMENTAL
Intervention: 17alpha‐hydroxyprogesterone caproate
Number of subjects: 463

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 463
Study: 11491011

Group type: EXPERIMENTAL
Intervention: Diethylcarbamazine (DEC) 6 mg/kg
Number of subjects: 26800

Group type: EXPERIMENTAL
Intervention: Ivermectin 400 micrograms/kg
Number of subjects: 26800

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26800
Study: 9554833

Group type: EXPERIMENTAL
Intervention: Diluted diesel exhaust (300mg m(‐3) particulates, 1.6ppm nitrogen dioxide)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Filtered air
Number of subjects: 15
Study: 8089358

Group type: EXPERIMENTAL
Intervention: Fibrel implant
Number of subjects: 0
Study: 2782121

Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 15
Study: 4603999

Group type: EXPERIMENTAL
Intervention: 5 mg prednisone, daily for a week
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 29916784

Group type: EXPERIMENTAL
Intervention: Basic information about PSA screening
Number of subjects: 1208

Group type: EXPERIMENTAL
Intervention: Didactic information about screening risks and benefits
Number of subjects: 1208

Group type: EXPERIMENTAL
Intervention: Narrative stories about physical harm, emotional harm, overdiagnosis, or all 3 stories
Number of subjects: 1208
Study: 27383558

Group type: EXPERIMENTAL
Intervention: mRDTs used by CHWs
Number of subjects: 1355

Group type: COMPARATOR
Intervention: Presumptive diagnosis by CHWs
Number of subjects: 1355
Study: 24655464

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral group
Number of subjects: 82

Group type: COMPARATOR
Intervention: Bibliotherapy
Number of subjects: 82

Group type: COMPARATOR
Intervention: Brochure control
Number of subjects: 82
Study: 22855914

Group type: EXPERIMENTAL
Intervention: UHV-HPMC (4 g)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Psyllium fiber (4 g)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 20471544

Group type: EXPERIMENTAL
Intervention: Handheld fan directed to the face
Number of subjects: 50

Group type: COMPARATOR
Intervention: Handheld fan directed to the leg
Number of subjects: 50
Study: 18331577

Group type: EXPERIMENTAL
Intervention: Clinical case management group (CMG)
Number of subjects: 370

Group type: COMPARATOR
Intervention: Standard care group (SCG)
Number of subjects: 370

Group type: COMPARATOR
Intervention: No-treatment group (NTG)
Number of subjects: 370
Study: 16435701

Group type: EXPERIMENTAL
Intervention: Horn sounds recorded in three test vehicles presented in quiet
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Horn sounds recorded in three test vehicles presented with engine idling, fan off
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Horn sounds recorded in three test vehicles presented with engine idling, fan on
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Horn sounds recorded in three test vehicles presented while vehicle moving at 30 mph, fan off
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Horn sounds recorded in three test vehicles presented while vehicle moving at 30 mph, fan on
Number of subjects: 20
Study: 12907528

Group type: EXPERIMENTAL
Intervention: Smoking cessation plus inhaled ipratropium bromide
Number of subjects: 5887

Group type: EXPERIMENTAL
Intervention: Smoking cessation plus placebo inhaler
Number of subjects: 5887

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 5887
Study: 10097995

Group type: EXPERIMENTAL
Intervention: Autistic individuals
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Down individuals
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (normal development)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Identity and emotional situation subtasks
Number of subjects: 30
Study: 8904946

Group type: EXPERIMENTAL
Intervention: Guided Self‐Change (GSC)
Number of subjects: 788

Group type: COMPARATOR
Intervention: Educational Materials Control (EMC)
Number of subjects: 788
Study: 1867242

Group type: EXPERIMENTAL
Intervention: Patients with hypertension
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Patients older than 75 years
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Patients with both hypertension and age over 75 years
Number of subjects: 265

Group type: COMPARATOR
Intervention: Control group (nonrheumatic atrial fibrillation without stroke)
Number of subjects: 265
Study: 6139327

Group type: EXPERIMENTAL
Intervention: Fluspirilene
Number of subjects: 82

Group type: COMPARATOR
Intervention: Bromazepam
Number of subjects: 82
Study: 29651668

Group type: EXPERIMENTAL
Intervention: Chitosan nanoparticle
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: QMix
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: EDTA
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 60
Study: 29412705

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (AE)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Combined exercise (CE)
Number of subjects: 41
Study: 27527344

Group type: EXPERIMENTAL
Intervention: Restrictive transfusion threshold (eligible for transfusion if post-operative haemoglobin < 7.5 g/dl)
Number of subjects: 2007

Group type: COMPARATOR
Intervention: Liberal transfusion threshold (eligible for transfusion immediately after randomisation if post-operative haemoglobin < 9 g/dl)
Number of subjects: 2007

Group type: EXPERIMENTAL
Intervention: Restrictive transfusion threshold
Number of subjects: 2007

Group type: COMPARATOR
Intervention: Liberal transfusion threshold
Number of subjects: 2007
Study: 24036678

Group type: EXPERIMENTAL
Intervention: Partners Together in Health (PaTH) intervention
Number of subjects: 34

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: PaTH intervention
Number of subjects: 34
Study: 22869534

Group type: EXPERIMENTAL
Intervention: Conventional sphincterotomy (GI)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: V‐Y advancement flap (GII)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Combined tailored lateral sphincterotomy with V‐Y advancement flap (GIII)
Number of subjects: 150
Study: 20336999

Group type: EXPERIMENTAL
Intervention: Trigger point acupuncture
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 1% lidocaine infiltration of trigger points
Number of subjects: 21
Study: 17030104

Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (HRT) - estrogen plus progesterone
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (untreated women)
Number of subjects: 40
Study: 15793193

Group type: EXPERIMENTAL
Intervention: Oral glucose tolerance test (OGTT) at baseline and after approximately 2 years
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Severe obesity, impaired glucose tolerance, and African-American background
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Changes in insulin sensitivity related to weight change
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Fasting glucose, insulin, and C-peptide
Number of subjects: 117
Study: 12226608

Group type: EXPERIMENTAL
Intervention: Self-etching primer (Transbond Plus Self Etching Primer, 3M Unitek) left for 15 seconds before bonding
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Self-etching primer (Transbond Plus Self Etching Primer, 3M Unitek) left for 2 minutes before bonding
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Self-etching primer (Transbond Plus Self Etching Primer, 3M Unitek) left for 10 minutes before bonding
Number of subjects: 48

Group type: COMPARATOR
Intervention: Conventional etchant and separate primer (control group)
Number of subjects: 48
Study: 10654357

Group type: EXPERIMENTAL
Intervention: HTK
Number of subjects: 959

Group type: COMPARATOR
Intervention: UW
Number of subjects: 959

Group type: COMPARATOR
Intervention: EC
Number of subjects: 959
Study: 7792438

Group type: EXPERIMENTAL
Intervention: rhDNase 0.6, 2.5, 10 mg
Number of subjects: 968

Group type: EXPERIMENTAL
Intervention: rhDNase 2.5 mg, once or twice daily
Number of subjects: 968

Group type: COMPARATOR
Intervention: rhDNase
Number of subjects: 968

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 968
Study: 2235167

Group type: EXPERIMENTAL
Intervention: Prednisone for 7 days plus trimethoprim-sulfamethoxazole (TMP/SMZ) for 30 days
Number of subjects: 53

Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole (TMP/SMZ) alone
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Overall treatment (including crossover)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Prednisone plus TMP/SMZ
Number of subjects: 53

Group type: COMPARATOR
Intervention: TMP/SMZ alone
Number of subjects: 53
Study: 369049

Group type: EXPERIMENTAL
Intervention: Supervised oral hygiene action with amine fluoride-containing agents Silca and Elmex fluid
Number of subjects: 18
Study: 31283565

Group type: EXPERIMENTAL
Intervention: Negative Pressure Wound Therapy (NPWT)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Standard dressing (control)
Number of subjects: 139
Study: 30394916

Group type: EXPERIMENTAL
Intervention: 3‐Hydroxy‐3‐Methylglutaryl‐CoA Reductase genetic score
Number of subjects: 832

Group type: EXPERIMENTAL
Intervention: Proprotein Convertase Subtilisin/Kexin type 9 genetic score
Number of subjects: 832

Group type: COMPARATOR
Intervention: Low low‐density lipoprotein levels
Number of subjects: 832
Study: 28777365

Group type: EXPERIMENTAL
Intervention: Reslip (doxylamine)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Donormyl
Number of subjects: 60
Study: 25596660

Group type: COMPARATOR
Intervention: Chemoradiotherapy (three cycles of cisplatin 100 mg/m(2))
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Panitumumab plus chemoradiotherapy (three cycles of intravenous panitumumab 9.0 mg/kg every 3 weeks plus cisplatin 75 mg/m(2))
Number of subjects: 150

Group type: COMPARATOR
Intervention: Chemoradiotherapy
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Panitumumab plus chemoradiotherapy
Number of subjects: 150
Study: 23131530

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 1 mg/kg/day as morning dose
Number of subjects: 100

Group type: COMPARATOR
Intervention: General preventive measures for UTI
Number of subjects: 100
Study: 22379918

Group type: EXPERIMENTAL
Intervention: FFP 5423+417 ml and crystalloids 11048+458 ml (1:2 ratio)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: FFP 6882+943 ml and crystalloids 6690+882 ml (1:1 ratio)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: FFP 7532+1196 ml and crystalloids 3720+629 ml (2:1 ratio)
Number of subjects: 66
Study: 19364893

Group type: EXPERIMENTAL
Intervention: Mobile health technology with blood glucose sensor and Bluetooth transmission
Number of subjects: 137

Group type: COMPARATOR
Intervention: Usual care without telemonitoring
Number of subjects: 137
Study: 16356651

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 15058858

Group type: EXPERIMENTAL
Intervention: Prior items of varying difficulty (easy vs. difficult)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intermediate-difficulty items following easy items
Number of subjects: 0
Study: 11124005

Group type: EXPERIMENTAL
Intervention: failure feedback
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: success feedback
Number of subjects: 54

Group type: COMPARATOR
Intervention: neutral control task
Number of subjects: 54
Study: 9050390

Group type: EXPERIMENTAL
Intervention: Trick task
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Reduced information processing task
Number of subjects: 68

Group type: COMPARATOR
Intervention: Standard appearance-reality task
Number of subjects: 68
Study: 7514771

Group type: EXPERIMENTAL
Intervention: Morphine or Heroin (specific dosage not mentioned)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Definite nociceptive pain
Number of subjects: 168
Study: 3315824

Group type: EXPERIMENTAL
Intervention: Endoscopic intravariceal sclerotherapy
Number of subjects: 66

Group type: COMPARATOR
Intervention: Percutaneous transhepatic obliteration (PTO)
Number of subjects: 66
Study: 30928252

Group type: EXPERIMENTAL
Intervention: ICRS followed by CXL (concurrent)
Number of subjects: 198

Group type: COMPARATOR
Intervention: ICRS followed by CXL 3 months later (sequential)
Number of subjects: 198
Study: 28485659

Group type: EXPERIMENTAL
Intervention: self‐generation learning program (self‐GEN trial)
Number of subjects: 35

Group type: COMPARATOR
Intervention: placebo control
Number of subjects: 35
Study: 27798042

Group type: EXPERIMENTAL
Intervention: 6-month lifestyle intervention preceding infertility treatment
Number of subjects: 577

Group type: COMPARATOR
Intervention: Prompt infertility treatment
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: 6-month lifestyle intervention
Number of subjects: 577
Study: 25373067

Group type: EXPERIMENTAL
Intervention: Rubber mannequin IV training arms
Number of subjects: 260

Group type: COMPARATOR
Intervention: Students performing the procedure on each other
Number of subjects: 260
Study: 22270749

Group type: EXPERIMENTAL
Intervention: Local anesthetic only
Number of subjects: 60

Group type: COMPARATOR
Intervention: Local anesthetic mixed with non-particulate betamethasone
Number of subjects: 60
Study: 20817598

Group type: EXPERIMENTAL
Intervention: Doxepin 6mg (DXP)
Number of subjects: 565
Study: 17982321

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba (EGb 761, 300 mg/day)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 14768768

Group type: EXPERIMENTAL
Intervention: Experimental audiotape incorporating components of protection motivation theory
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Standard asthma management booklet
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Combined group (audiotape and booklet)
Number of subjects: 46

Group type: COMPARATOR
Intervention: No educational materials (control group)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group vs. Booklet group
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group vs. Combined group
Number of subjects: 46
Study: 11073288

Group type: EXPERIMENTAL
Intervention: 100 mg oral dose of imiquimod after fasting
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 100 mg oral dose of imiquimod after a standardized, high fat meal
Number of subjects: 16

Group type: COMPARATOR
Intervention: 30 mg subcutaneous dose of imiquimod
Number of subjects: 16
Study: 9198818

Group type: EXPERIMENTAL
Intervention: Phenazone
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Acetylation phenotype
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (healthy women)
Number of subjects: 41
Study: 1319110

Group type: EXPERIMENTAL
Intervention: Psyllium-enriched cereal (114 g/d)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Wheat-bran cereal
Number of subjects: 44
Study: 2984980

Group type: EXPERIMENTAL
Intervention: Intranasally administered enviroxime
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (untreated group)
Number of subjects: 0
Study: 3694540

Group type: EXPERIMENTAL
Intervention: Lorazepam (LZ) 1.5‐9.0 mg
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Meprobamate (MEP) 600‐3600 mg
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 30972904

Group type: EXPERIMENTAL
Intervention: Knutson's formula (povidone-iodine and sugar solution)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Traditional topical drugs
Number of subjects: 34
Study: 29095379

Group type: EXPERIMENTAL
Intervention: Patterned Feeding Experience (PFE)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Usual Feeding Care (UFC)
Number of subjects: 7
Study: 25585890

Group type: EXPERIMENTAL
Intervention: Proton therapy at a dose of 54 Gy in 30 fractions
Number of subjects: 20
Study: 23683448

Group type: EXPERIMENTAL
Intervention: 5mL.kg(‐1) of 0.9% normal saline 10 minutes before induction
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group (received nothing)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Both groups (saline and control)
Number of subjects: 69
Study: 20673739

Group type: EXPERIMENTAL
Intervention: Longer stimulus durations (blocked presentation mode) in Experiment 2
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomized stimulus durations in Experiment 1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increasing stimulus duration (both experiments)
Number of subjects: 0
Study: 18781484

Group type: COMPARATOR
Intervention: Normal saline infusion
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 20% glucose infusion
Number of subjects: 10
Study: 16505084

Group type: EXPERIMENTAL
Intervention: Sodium supplementation (620 mg table salt)
Number of subjects: 413

Group type: COMPARATOR
Intervention: Placebo (596 mg starch)
Number of subjects: 413

Group type: COMPARATOR
Intervention: No supplementation
Number of subjects: 413
Study: 12740158

Group type: EXPERIMENTAL
Intervention: HPS cream (Crystacide 1%) applied topically twice daily for 8 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Benzoyl peroxide gel (PanOxyl gel 4%) applied topically twice daily for 8 weeks
Number of subjects: 60
Study: 12903500

Group type: EXPERIMENTAL
Intervention: Oral furtulon therapy
Number of subjects: 103

Group type: COMPARATOR
Intervention: Instillation of mitomycin C
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 103
Study: 9313274

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Hydromorphone
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Sufentanil
Number of subjects: 119

Group type: COMPARATOR
Intervention: All three opioids (morphine, hydromorphone, sufentanil)
Number of subjects: 119
Study: 7691253

Group type: EXPERIMENTAL
Intervention: Intensive weekly chemotherapy (VAPEC-B) alone
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Intensive weekly chemotherapy (VAPEC-B) with granulocyte colony-stimulating factor (G-CSF)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Chemotherapy alone or chemotherapy with G-CSF
Number of subjects: 50
Study: 3536397

Group type: EXPERIMENTAL
Intervention: 20 mg ISDN
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: 40 mg ISDN
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: 60 mg ISDN
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: 80 mg ISDN
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: ISDN (all doses)
Number of subjects: 49
Study: 30318772

Group type: EXPERIMENTAL
Intervention: Cetuximab treatment in patients with FCGR2A H/H genotype (n=165, 28%)
Number of subjects: 592

Group type: COMPARATOR
Intervention: Cetuximab treatment in patients with FCGR2A R/- genotype (n=427, 72%)
Number of subjects: 592

Group type: EXPERIMENTAL
Intervention: Cetuximab treatment in patients with FCGR2A H/R genotype
Number of subjects: 592

Group type: EXPERIMENTAL
Intervention: Cetuximab treatment in patients with FCGR2A H/H + FCGR3A F/F genotype
Number of subjects: 592

Group type: EXPERIMENTAL
Intervention: Cetuximab treatment
Number of subjects: 592
Study: 27873423

Group type: EXPERIMENTAL
Intervention: Smile intervention (performing an easy cognitive task while smiling; n = 11)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (performing an easy cognitive task without smiling; n = 9)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Smile intervention
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 24114425

Group type: EXPERIMENTAL
Intervention: Mecamylamine 10 mg
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Varenicline 1 mg
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study: 23124047

Group type: EXPERIMENTAL
Intervention: DPP-based lifestyle intervention
Number of subjects: 241

Group type: COMPARATOR
Intervention: Contact attempted for 2391 patients
Number of subjects: 241

Group type: COMPARATOR
Intervention: Screening of patients
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: All clinic physicians agreed to participate
Number of subjects: 241
Study: 20034947

Group type: EXPERIMENTAL
Intervention: Triple dye plus rubbing alcohol (isopropyl alcohol) twice daily
Number of subjects: 90

Group type: COMPARATOR
Intervention: Triple dye alone (brilliant green, crystal violet, and proflavine hemisulfate)
Number of subjects: 90
Study: 18665684

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Multidimensional family therapy (MDFT)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Therapist competence
Number of subjects: 136
Study: 16632346

Group type: EXPERIMENTAL
Intervention: Chemotherapy followed by craniospinal RT (35 Gy in 21 fractions + boost of 20 Gy in 12 fractions)
Number of subjects: 68

Group type: COMPARATOR
Intervention: RT alone
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Pineal primary site
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Non-pineal primary site
Number of subjects: 68
Study: 12752841

Group type: EXPERIMENTAL
Intervention: Psychosocial interventions for caregivers
Number of subjects: 30
Study: 11049903

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 453

Group type: COMPARATOR
Intervention: Thiopental and Isoflurane
Number of subjects: 453

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 453
Study: 8835126

Group type: EXPERIMENTAL
Intervention: Cow's milk challenge
Number of subjects: 100
Study: 1424853

Group type: EXPERIMENTAL
Intervention: Continuous monitoring with pulse oximetry available at the bedside (group 1)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Continuous monitoring with pulse oximetry masked at the bedside (group 2)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Continuous monitoring with pulse oximetry (group 2)
Number of subjects: 35